Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How often should liver function be checked while on bosentan?

Recommended Liver Monitoring Schedule for Bosentan


Bosentan (Tracleer), used for pulmonary arterial hypertension, requires regular liver function tests (LFTs) due to risk of hepatotoxicity. Start monitoring before treatment and continue at these intervals:

- Before starting: Check ALT, AST, and bilirubin within 3 days.[1][2]
- First two weeks: Test LFTs weekly.[1][2]
- Weeks 3 through month 3: Test LFTs monthly.[1][2]
- After month 3: Test LFTs every 3 months.[1][2]

Adjust or stop treatment if ALT/AST exceed 3x upper limit of normal (ULN), or 2x ULN with elevated bilirubin.[1]

What If Liver Enzymes Are Elevated?


Dose reduction or discontinuation depends on severity:
- ALT/AST >3x but ≤5x ULN: Reduce dose and monitor weekly until normalized.
- ALT/AST >5x ULN or >3x ULN with symptoms: Stop bosentan immediately.
- Retest within 48 hours if initial elevation is confirmed.[1][2]

Patients with baseline liver issues or other hepatotoxic drugs need closer monitoring.[1]

Why Such Frequent Checks?


Bosentan can cause asymptomatic liver enzyme rises in up to 11% of patients, with rare serious injury. Early detection prevents progression; FDA-mandated REMS program (Tracleer Access Program) enforces this.[1][2]

Bosentan vs. Other Endothelin Antagonists


| Drug | Initial Monitoring | Ongoing |
|------|---------------------|---------|
| Bosentan | Weekly x2 weeks, monthly x3 months | Every 3 months [1] |
| Ambrisentan | Monthly x3 months, then every 3-6 months [3] |
| Macitentan | Monthly x3 months, then every 6-12 months [3] |

Bosentan has the strictest schedule due to higher hepatotoxicity rates.

Patient Tips and Alternatives


Report nausea, fatigue, jaundice, or dark urine promptly. Pregnancy testing is also monthly via REMS.[1] Alternatives like macitentan have lower liver risks but similar efficacy in trials.[3]

No specific patents listed for monitoring protocols on DrugPatentWatch.com.

Sources

[1] Tracleer (bosentan) Prescribing Information
[2] FDA REMS for Tracleer
[3] Opsumit (macitentan) and Letairis (ambrisentan) Prescribing Information



Other Questions About Liver :

Is liver damage a common side effect of mixing lipitor alcohol? What liver related contraindications exist for lipitor use? Have you had any liver function tests since taking lipitor generics? Can quitting alcohol reverse liver damage from lipitor? Can phosphatidylcholine support liver health? What liver related dangers come with lipitor alcohol use? Is there a link between alcohol and increased liver problems in lipitor users?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy